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Abstract 
Review on CXCL12, with data on DNA, on the 
protein encoded, and where the gene is implicated. 
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Identity 
Other names: SDF-1, PBSF, SCYB12, TLSF, 
TPAR1, SDF-1A, SDF-1B, SDF-1a, SDF-1b, IRH 
HGNC (Hugo): CXCL12 
Location: 10q11.21 
Local order: Molecular Location: Chromosome 
10; base pairs 44,865,601-44,880,545 reverse 
strand, in the February 2009 hg19 human assembly 
(GRCh37).  
According to UCSC Genome Browser on Human 
Feb. 2009 assembly (GRCh37/hg19), genes 
flanking CXCL12 on 10q11.21, in centromere to 
telomere direction, are ZNF32 (zinc finger protein 
32), HNRNPA3P1 (heterogeneous nuclear 
ribonucleoprotein A3 pseudogene 1), CXCL12, 
THEM72 (transmembrane protein 72), RASSF4 
(Ras association (RalGDS/AF-6) domain family 
member 4). 
Note 
Synonyms: Stromal cell-derived factor 1, Pre-B cell 
growth-stimulating factor, Intercrine reduced in 
hepatomas. 
DNA/RNA 
Description 
The CXCL12 gene consists of 4 exons spanning 
14.94 kb on the chromosome 10 at band q11.21 
(reverse strand) (Figure 1). 
Transcription 
Alternative splicing results in eight transcript 
variants (Table 1), as shown in Ensembl database. 
Among them, six correspond to as many protein 
isoforms (Yu et al., 2006). 
Pseudogene 
No known pseudogenes. 
Protein 
Description 
CXCL12 gene encodes a stromal cell-derived alpha 
chemokine, also known as SDF1, a member of the 
intercrine family.  
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Figure 1 Schematic structure of the four exons of human CXCL12 (exon1: 153bp; exon2: 118bp; exon3: 87bp; exon4: 3191bp). 
Two of them are made up not only of coding regions (in green color) but also of non-coding ones (in red color). 
 
 
 
 
Figure 2 The figure shows (A)the molecule processing of CXCL12 beta isoform sequence, in which the potential signal peptide 
is marked in red color while the polypeptide chain in blue color (data obtained from UniProtKB database);(B) the multiple 
sequence alignment of the six CXCL12 isoforms. For each isoform, after the 88 identical positions there are a certain number of 
different residues, highlighted in light blue color. (Alignment produced by CLC Sequence Viewer 7.0 from CLCbio - QIAGEN 
Company, using Clustal Omega multiple alignment program). SDF-1-alpha(3-67) and SDF-1-beta(3-72), processed by post-
translational proteolytic cleavage, are marked by yellow and orange boxes respectively (data on both sequences belong to 
UniProtKB database). 
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This family is defined by the location of the first 
two cysteine residues in the sequence, which are 
separated by one amino acid (C-X-C 
chemokine)(Hromas, 1997). Six protein isoforms 
have been identified in human: Alpha, Beta, 
Gamma, Delta, Epsilon and Theta (Table 2; Figure 
2), produced by alternative splicing events (Yu et 
al., 2006).  
In particular Alpha and Beta isoforms, secreted as 
full-length molecules, undergo to post-translational 
modifications by a proteolytic cleavage, becoming 
respectively processed forms SDF-1-alpha(3-67) 
and SDF-1-beta(3-72)(De la Luz Sierra et al., 
2004). The Beta isoform has been chosen as the 
canonical sequence and, together with Alpha 
isoform, is ubiquitously expressed in liver, pancreas 
and spleen. The Gamma Isoform is mainly 
expressed in heart, while the isoforms Delta, 
Epsilon and Theta are mainly expressed in 
pancreas. In the developmental stage, the isoform 
Alpha is ubiquitously expressed in fetal tissues, 
Beta and Delta isoforms in fetal spleen and liver, 
while Gamma and Theta isoforms are weakly 
detected in fetal kidney (Yu et al., 2006). 
Expression 
CXCL12 is widely expressed in a variety of tissue 
types, such as heart, liver, spleen, kidney, brain, 
skeletal muscle, endothelium, epithelium, lymphoid 
organs, stem cells as well as overexpressed in 
cancer cells (Kryczek et al., 2007; Teicher and 
Fricker, 2010). 
Localisation 
Extracellular region. 
Function 
The CXCL12 protein functions as a ligand for two 
seven-transmembrane receptors (7-TMRs). The first 
one is the chemokine (C-X-C motif) receptor 4 
(CXCR4), a monogamous receptor that signals 
through heterotrimeric G proteins and beta-arrestin; 
the second one is the chemokine (C-X-C motif) 
receptor 7 (CXCR7), a non-monogamous receptor 
that does not activate G-protein-mediated signal 
transduction but signals only through beta-arrestin 
(Oberlin et al., 1996; Rajagopal et al., 2010; Sun et 
al., 2010; Zhu et al., 2012; Sanchez-Martin et al., 
2013). In particular, CXCL12 has a higher affinity 
of binding to CXCR7 than to CXCR4 (Zhu et al., 
2012), even if its affinity to CXCR7 seems to be 
reduced by the expression of CXCR4 at the 
membrane (Sanchez-Martin et al., 2013). CXCL12 
is secreted in the extracellular space as monomeric 
and dimeric forms, which can trigger different 
effects on cell signaling (Ray et al., 2012). In fact, 
whereas CXCR4 binds both monomeric and 
dimeric forms, CXCR7 binds preferentially the 
dimeric one (Sanchez-Martin et al., 2013).  
For example, dimeric CXCL12 form induces 
calcium mobilization but fails to promote 
chemotaxis, which is induced by the monomer-
based interactions (Ray et al., 2012; Sanchez-
Martin et al., 2013).  
Many others cellular functions depend on CXCL12 
activity, including embryogenesis, apoptosis and 
survival, immune response, tissue homeostasis, 
angiogenesis, calcium ion homeostasis, clathrin-
mediated endocytosis, cytoskeletal rearrangement, 
cell proliferation and migration, tumor growth and 
metastasis (Vlahakis et al., 2002; Goda et al., 2006; 
Petit et al., 2007; Khan et al., 2008; Agle et al., 
2010; Drury et al.,2010; Karin, 2010; Kremer, 
2010; Sun et al., 2010; Zhu et al., 2012). 
Homology 
The CXCL12 Gene Tree shows a great 
evolutionary conservation across species (Figure 3). 
The internal nodes of the phylogenetic tree are 
annotated for duplication (red boxes) and speciation 
(blue boxes) events, which correspond to paralogs 
and orthologs homologous genes respectively. 
Mutations 
Note 
It has been suggested that a single nucleotide 
polymorphism (SNP)in the 3' untranslated region of 
SDF-1-beta transcript is associated not only with a 
delayed onset (Winkler et al., 1998) and a modest 
protective effect against infection and progression 
of AIDS (Modi et al., 2005), but also with the early 
onset of type 1 diabetes (Dubois-Laforgue et al., 
2001) and with an increased likelihood of 
developing several cancers (as lung, breast, 
colorectal and prostate)(Ma et al., 2012; Shi et al., 
2013).  
This could be explained by an increased level and 
stability of SDF-1-beta transcript as effect of this 
mutation (Garcia-Moruja et al., 2009). 
Somatic 
A SNP consisting of a G-to-A transition at position 
801, counting from the ATG start codon in the 3' 
UTR of the Genbank reference sequence L36033, 
was represented in the SDF-1-beta transcript but 
not in the SDF-1-alpha transcript (Winkler et al., 
1998). The mutation CXCL12-G801A-3 Prime 
UTR, also known as SDF1-3-prime-A, located at 
chromosome 10 position 44873550 on Assembly 
GRCh37, has been classified as pathogenic variant 
(dbSNP: rs387906400)related to the phenotype 
Human immunodeficiency virus type 1, resistance 
to (OMIM: 600835.0001). 
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Figure 3 The CXCL12 Gene Tree shows the maximum likelihood phylogenetic tree representing the evolutionary history of the 
CXCL12 gene, constructed using the alignment of a CXCL12 representative protein for each species (green bars). The Gene 
tree has been generated by Ensembl (GeneTree ENSGT00390000014056 - August 2015) using the Gene Orthology/Paralogy 
prediction method pipeline (Vilella et al., 2009). 
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Implicated in 
Lung cancer 
The CXCL12 expression showed an increase in 
lung cancer cell lines (small cell lung cancers and 
non-small cell lung cancers) compared to non-
malignant human bronchial epithelial cell ones. 
This overexpression was positively but weakly 
correlated with those of CXCR4 or CXCR7, 
suggesting that CXCL12 may differentially interact 
with its receptors depending on the cellular context 
(Imai et al., 2010). Furthermore, different evidences 
support the involvement of the CXCL12/CXCR4 
axis, but not CXCL12/CXCR7, in the metastatic 
behavior of non-small cell lung cancer, suggesting 
their potential use as prognostic markers and drug 
targets (Paratore et al., 2011; Cavallaro, 2013; Choi 
et al., 2014). 
Breast cancer 
The CXCL12 expression has been shown to 
stimulate breast cancer cells proliferation and 
promote tumor growth (Allinen et al., 2004; Duda 
et al., 2011). Moreover, a CXCL12 gene variant 
CXCL12-A (CXCL12-G801A, a single nucleotide 
polymorphism in the 3' untranslated region) was 
associated with an increased susceptibility to breast 
cancer (Dimberg et al., 2007). The interactions of 
CXCL12/CXCR4 seems to have a critical role in 
determining the metastatic destination of breast 
cancer metastasis (Muller et al., 2001; Hinton et al., 
2011), while the CXCR7 expression has been 
linked to the ability of tumor cells to produce lung 
and brain metastasis (Sun et al., 2010). In a recent 
study, the expression profiles of the six CXCL12 
isoforms and both receptors have been investigated 
in a large clinical cohort and common breast cancer 
cell lines. As result, isoform-specific differences in 
expression and breast cancer outcomes have been 
established, while CXCR4 and CXCR7 showed an 
opposite pattern in cancer as compared with normal 
and further differences between hormone receptor 
status and molecular subtypes (Zhao et al., 2014). 
Other malignancies 
The importance of CXCL12 pathways in the 
proliferation, growth and metastasis processes has 
been assessed for many other types of tumors, 
among which prostate cancer (Vaday et. al., 2004; 
Zhang et al., 2008; Sun et al., 2010; Duda et al., 
2011), pancreatic adenocarcinoma (Shen et al., 
2013; Wu et al., 2013), neuroblastoma (Zagozdzon 
et al.,2008; Liberman et al., 2012), glioblastoma 
(Gatti et al., 2013; Wurth et al., 2014; Yao et al., 
2015), colorectal cancer (Brand et al., 2005; 
Akishima-Fukasawa et al., 2009; Drury et al., 
2010), melanoma (Scala et al., 2005; Toyozawa et 
al.,2012; Mitchell et al., 2014), bladder cancer 
(Retz et al., 2005; Shen et al., 2013), esophageal 
cancer (Sasaki et al., 2008; Wang et al., 2009; 
Tachezy et al., 2013), renal cancer (Pan et al., 2006; 
Ieran et al., 2014) and ovarian cancer (Popple et al., 
2012). 
Human Immunodeficiency Virus-type 
1 (HIV-1) infection 
Since the discovery of the leukocyte-derived seven-
transmembrane domain receptor (LESTR) twenty 
years ago (Loetscher et al., 1994) and of its function 
of co-receptor (termed fusin) for lymphocyte-tropic 
HIV-1 strains, the role of this chemokine receptor 
in modulating cell permissiveness to the infection 
was delineated in few years(Feng et al., 1996).  
At the same time, was reported the identification of 
the SDF-1 human chemokine as the natural ligand 
for LESTR/fusin protein, so named CXCR4, and its 
function of infection inhibitor by lymphocyte-tropic 
HIV-1 strains  (Bleul et al., 1996 ; Oberlin et al., 
1996).  
It was clarified that the HIV-1 infection requires 
expression of CD4, as primary receptor, and the 
CXCR4 as entry co-factor at the target cell surface; 
the engagement of these receptors by the HIV-1 
envelope glycoprotein is essential for membrane 
fusion and, HIV infection can be prevented by HIV 
co-receptor antagonists (Davis et al., 1997).  
The HIV suppressive activity of SDF-1, by 
inhibition of HIV replication, was explained by a 
SDF-1 alpha-dependent internalization of the 
CXCR4 (Amara et al., 1997).  
Furthermore, as previously described in the 
mutations section, the SDF-1-beta chemokine gene 
variant in the homozygous state (SDF1-3'A/3'A), 
has been correlate to a delay of the AIDS onset 
(Winkler et al., 1998).  
During these years, different CXCR4 antagonists 
have reached later stage clinical trials but no one is 
currently underway (Henrich and Kuritzkes, 2013). 
WHIM Syndrome 
WHIM is an acronym for an immunodeficiency 
disorder characterized by (w)arts, 
(h)ypogammaglobulinemia, (i)nfections and 
(m)yelokathexis symptoms.  
In most cases, it is caused by an inherited mutation 
affecting the CXCR4 gene (Hernandez et al., 2003; 
Liu et al., 2012). 
Autoimmune Diseases 
CXCL12 functions as an anti-inflammatory 
chemokine during autoimmune inflammatory 
responses suggesting the use of CXCL12-based 
therapies for autoimmune inflammatory diseases 
(Karin, 2010; Villalvilla et al., 2014). 
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